TABLE 1.

Meningococcal strains used in this studya

StrainClonal complexSTYrCountrySerogroup:serotype:serosubtypefHbp variant
MC5832741985UKB:15:P1.7,16b1.1
M01-024014941/44412001UKB:4:P1.7,41.4
M01-024018511112001UKB:2a:P1.5,101.10
NZ98/25441/44421998New ZealandB:4:P1.41.14
M157341/44441995USAB:P7-1,11.55
NL09641/441101960NetherlandsB:14:NT1-2,3.x
961-594581531996AustraliaB:2b:P1.21,162.16
M315341/4459061996USAB:4,7:P1.42.19
C11NA3451965CubaC:NT:P1.12.22
M25521031031996USAB:NT:NT2.25
M123941/444371994USAB:14:P1.23,143.28
M01-02403202132132001UKB:1:P1.22,143.45
  • a The fHbps are named in terms of the translated (protein) sequence, as variant class.protein ID, in accordance with the public fHbp database (http://neisseria.org), in which new protein subvariants are assigned a sequential numerical identifier, alongside a prefix corresponding to the Novartis variant designation (variant 1, 2, or 3). For example, fHbp 1.1 refers to Novartis variant 1, neisseria.org protein subvariant 1. Neisseria strain NL096 expresses a hybrid natural chimera of fHbp, hence, the designation 1-2,3.x (the x indicates that the peptide number has not yet been assigned). ST, sequence type as determined by MLST; NA, not assigned.